Collection of Blood Specimens for Circulating Tumor Cell Analysis

Viatar

Status: Completed

Conditions: Breast Cancer; Prostate Cancer; Colorectal Cancer

Study type: Observational

Funder types: Industry; Other

Identifiers

NCT01943500

T30-0001

Details and patient eligibility

About

Objective: To test the sensitivity of a proprietary novel filtration device designed to capture and concentrate circulating tumor cells (CTCs).

Enrollment: 14 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age > 18 years of age
• Written informed consent obtained
• Confirmed diagnosis of stage 2-4 breast, prostate, or colorectal cancer, (OR) no prior history of cancer
• Stage 2-4 treatment naive, metastatic, secondary, and recurrent cancer patients
• Able to undergo blood collection prior to initiation of chemotherapy treatment, (OR) able to provide blood sample if subject is a non-cancer control subject

Exclusion criteria

• Patients unable to understand the research protocol and/or provide informed consent.
• Patients with known immunodeficiency, or pregnancy.

Trial design

14 participants in 1 patient group

Cancer or no prior history of cancer

Description:

Confirmed patients with breast, prostate, or colorectal cancer (OR) subjects with no prior history of cancer